SKU: DMD3 | Last Updated On: 2019-04-09 | No. of Pages: 181 | Available Formats
SKU: DMD3 | Published On: 2019-04-09 | No. of Pages: 181 | Available Formats
The Global Advanced, Wound Care market, is estimated to reach a market value of USD 12,745.24 million by 2026 from an initial market value of USD 8,588.78 million in 2018. The market is forecasted to grow at a CAGR of 5.24% in the period 2019-2026.
Advancements in technologies, increasing aging population, rising prevalence of diabetics, and improving patient awareness and raising patient healthcare expenditure are some of the key factors driving the growth of the market.
The advancement in technologies in wound care products has significantly influenced the advancement of advanced products over traditional ones by clinicians and patients.
Advanced wound care technology – including V.A.C. technology by Kinetic Concepts that develops and promotes NPWT products, and hydro fiber and hydrocolloid technologies by ConvaTec – include some of the portable and user-friendly products introduced in the market.
Advanced wound care products are expensive compared to traditional wound dressing techniques. Therefore, many patients opt for traditional dressings despite its slow healing process.
This is one of the major challenges for the growth of the advanced wound dressings market globally.
The cost of treating chronic wounds in the U.S. is extremely high, with the charge per case ranging from 2,000 to 10,000 depending upon the condition and nursing costs. The cost of managing a pressure ulcer is estimated to be between 7,000 and 55,000 in the U.S., while the annual cost of all treatment is valued in billions. Unfavorable reimbursement policies are also restraining the growth of the market.
Exudate is the fluid leaking from the wound, which has a vital role in the healing process. It is mainly water but also consists of nutrients, proteins, waste products and various types of cells such as platelets and macrophages. Exudate management accounts for 32.10% of the total advanced wound care market in 2017.
Foam Dressing market accounts for the largest market share of 32% in 2017. The adoption of foam dressing is estimated to rise regardless of high prices majorly due to the large applications and flexibility in maintaining a moist atmosphere for diverse wound types. Some of the major players in the foam wound dressing segment include 3M Company, Smith & Nephew plc, ConvaTec, Inc. Acelity, Molnlycke Healthcare, Medline Industries, Hollister, Hartmann Paul, Derma Sciences, and Coloplast among others.
The advanced wound care market by wound type is segmented into chronic wounds and acute wounds. The chronic wounds market is the largest market and is estimated to have a market value of USD 8,102.75 million in 2021. In chronic wounds, venous pressure ulcer accounts for the largest market share followed by Diabetic Foot Ulcer. The prevalence of venous leg ulcer in U.K. is 1 to 3 per 1,000. Venous leg ulcer increases with age and reaches 16 to 18 per 1,000 in the 75+ age group. Changing reimbursement scenarios of biological products, increasing preferences of moist wound dressing products and the growing prevalence of venous leg ulcer are the significant factors driving the growth of the Venous leg ulcer market.
Segmentation by Products
Silicone Lite Foam Dressing
Silicone absorbent Dressing
Silicone Gel Sheets
Silver Wound Dressing
Active Wound Care
Bioengineered skin/synthetic Substitutes
Harmful Pressure Wound Therapies (NPWT Devices)
Conventional Negative Pressure Wound Therapy
Single Use Negative Pressure Wound Therapy
Hyperbaric Oxygen Therapy
Ultrasonic Mist and Electrical Stimulation Devices
1Full Compression – 2 layer
By Wound Type
Pressure Ulcer (PU)
Venous Leg Ulcer (VLU)
Diabetic Foot Ulcer (DFU)
Advanced Wound Care Geography Share
The North American market is expected to retain its dominant position globally by the end of the forecasted period owing to a high incidence rate of diabetic foot ulcer cases. Moreover, other regions such as South-East Asia are also expected to grow at a higher rate due to the high incidence of severe burn-related wounds in such areas.
The advanced wound care market is expected to witness a high growth rate in developing countries such as China. India and Brazil. Substantial innovations and top product launches are seen in North America and European regions. Companies headquartered in developed region dominate the market share due to their advancements and innovations in product development.
Advanced Wound Care Companies
The global advanced wound care market is a consolidated market with top 8 companies accounting for more than 75% of the market share. Acelity is the leading company in the advanced wound care market accounting for around 19% of the global stock in 2017.
Efficient distribution networks, product differentiation, and supply competency play a significant role in determining the market position of major companies. The market in North America and Europe are fairly consolidated while the market is relatively fragmented in the Asia-Pacific region due to the presence of a large number of companies.
Reasons for purchasing this report
Visualize the composition of the Global Advanced Wound Care Market across each indication, regarding type and applications, highlighting the critical commercial assets and players.
Identify business opportunities in the Global Advanced Wound Care Market by analyzing trends and co-development deals.
Excel data sheet with thousands of data points of the Global Advanced Wound Care Market level 4/5 segmentation
PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study
Product mapping in excel for the crucial Global Advanced Wound Care Market products of all major market players.
Who can benefit from this report?
Raw Material Suppliers/ Buyers
Product Suppliers/ Buyers
Industry Investors/Investment Bankers
Education & Research Institutes
1.2 Scope of the Report
3.1 Market Drivers
3.1.1 Advancements in Technologies
3.1.2 Increasing Aging Population
3.1.3 Rising Prevalence of Diabetics
3.1.4 Increasing patient awareness and raising patient healthcare expenditure
3.2 Market Restraints
3.2.1 High Cost of Advanced Wound Care Products
3.2.2 Unfavourable Reimbursement Products
3.3 Porters Five Forces
4.1 Segmentation by Products
4.1.1 Exudate Management
18.104.22.168 Silicone Dressing
22.214.171.124.1 Silicone Lite Foam Dressing
126.96.36.199.2 Silicone absorbent Dressing
188.8.131.52.3 Silicone gel Sheets
184.108.40.206 Super Absorbent
4.1.2 Infection Management
220.127.116.11 Silver Wound Dressing
18.104.22.168 Collagen Dressing
22.214.171.124 Non-Silver Dressing
4.1.3 Active Wound Care
126.96.36.199 Skin Substitutes
188.8.131.52.3 Placenta/Amniotic Tissue
184.108.40.206.4 Bioengineered skin/synthetic Substitutes
4.1.4 Therapy Devices
220.127.116.11 Negative Pressure Wound Therapies (NPWT Devices)
18.104.22.168.1Conventional Negative Pressure Wound Therapy
22.214.171.124.3 Dressing Kits
126.96.36.199.2 Single Use Negative Pressure Wound Therapy
188.8.131.52 Hyperbaric Oxygen Therapy
184.108.40.206 Ultrasonic Mist and Electrical Stimulation Devices
4.1.5 Compression Bandage
220.127.116.11 1Full Compression – 2 layer
4.1.6 Hemostatic Dressing
4.1.7 Nanofibre Dressing
4.2 By Wound Type
4.2.1 Chronic Wounds
18.104.22.168 Pressure Ulcer (PU)
22.214.171.124 Venous Leg Ulcer (VLU)
126.96.36.199 Diabetic Foot Ulcer (DFU)
4.2.2 Acute Wounds
5.1 North America
5.1.1 United States
5.1.4 Rest of North America
5.2.3 United Kingdom
5.2.6 Rest of Europe
5.3.5 Rest of Asia-Pacific
5.4 South America
5.4.3 Rest of South America
5.5 Rest of South America
6.1 Therapeutic Dressing
6.2 Topical Products
7.1 Market Share Analysis
7.2 Key Strategies Adopted by Major Players
8.1 3M Healthcare
8.2 Urgo Medical
8.3 B.Braun Medical
8.4 Coloplast A/s
8.5 ConvaTec Inc
8.6 Derma Sciences, Inc.
8.7 Paul Hartmann AG
8.8 Smith & Nephew
8.9 Medline Industries, Inc.
8.11 Molnlycke Healthcare
9.1 About Us